Showing results (81-90 of 117) with videos related to

Sort By:
Pageof 12
Bone Marrow Transplantation|February 23, 2016
Hematopoietic stem cell transplantation in Europe 2014: more than 40 000 transplants annuallyJ R Passweg, H Baldomero, P Bader, et al.
Bone Marrow Transplantation|July 2, 2013
Risk factors and containment of respiratory syncytial virus outbreak in a hematology and transplant unitN Lehners, P Schnitzler, S Geis, et al.
Bone Marrow Transplantation|February 3, 2015
Hematopoietic SCT in Europe 2013: recent trends in the use of alternative donors showing more haploidentical donors but fewer cord blood transplantsJ R Passweg, H Baldomero, P Bader, et al.
Bone Marrow Transplantation|January 16, 2021
Durable benefit of rituximab maintenance post-autograft in patients with relapsed follicular lymphoma: 12-year follow-up of the EBMT lymphoma working party Lym1 trialR Pettengell, R Uddin, A Boumendil, et al.
Bone Marrow Transplantation|March 24, 2015
Indications for allo- and auto-SCT for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2015A Sureda, P Bader, S Cesaro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 11, 2016
Reduced intensity allogeneic stem cell transplantation for follicular lymphoma relapsing after an autologous transplant achieves durable long-term disease control: an analysis from the Lymphoma Working Party of the EBMT†S P Robinson, A Boumendil, H Finel, et al.
Leukemia|August 13, 2010
The impact of HLA matching on long-term transplant outcome after allogeneic hematopoietic stem cell transplantation for CLL: a retrospective study from the EBMT registryM Michallet, M Sobh, D Milligan, et al.
Bone Marrow Transplantation|May 1, 2012
The EBMT activity survey: 1990-2010J R Passweg, H Baldomero, A Gratwohl, et al.
Bone Marrow Transplantation|February 9, 2016
Allogeneic hematopoietic cell transplantation as curative therapy for non-transformed follicular lymphomasF Heinzelmann, W Bethge, D W Beelen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 17, 2017
Salvage high-dose chemotherapy in female patients with relapsed/refractory germ-cell tumors: a retrospective analysis of the European Group for Blood and Marrow Transplantation (EBMT)U De Giorgi, S Richard, M Badoglio, et al.
Pageof 12